Aviadobio

Developer of gene therapies for neurodegenerative disorders

placeLondon, England, United Kingdom calendar_todayFounded 2019 groups38 employees language aviadobio.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 79 times.

YearFilings
20241
20251

Social engagement

Social engagement: 17.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include New Enterprise Associates, Monograph.

Investor typeCountShare
Venture capital764%
Private equity218%
Other / undisclosed218%

Recent activity

2 Jul 2026
Product launch
29 Jun 2026
Event
AAIC 2026
24 Jun 2026
Event
BIO 2026
Coming soon